Cruse Julius M, Lewis Robert E, Webb Rachel N, Sanders Catherine M, Suggs Jeanann L
Department of Pathology, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA.
Exp Mol Pathol. 2007 Dec;83(3):459-61. doi: 10.1016/j.yexmp.2007.08.009. Epub 2007 Sep 7.
Zeta-chain (TCR)-associated protein kinase 70 kDa (Zap-70) and CD38 expression may be of prognostic significance in chronic lymphocytic leukemia (CLL). Previous studies indicate that Zap-70 and CD38 are usually positive in cases of CLL with unmutated immunoglobulin variable region genes (IgVH) and may be used to predict IgVH mutation status and prognosis. Usually cases of CLL positive for Zap-70 or CD38 indicate a worse prognosis. In the present investigation, 47 cases of CLL were evaluated for CD38 expression, and 17 cases were evaluated for both Zap-70 and CD38 expression. Of the 47 cases, 19 (40.4%) positively expressed CD38. Of the 17 cases evaluated for Zap-70, 11 (64.7%) were positive for Zap-70, while only 6 (35.3%) were positive for CD38 expression; the remaining cases were negative for CD38. The results of this study show that Zap-70 expression may be a better indicator of the mutational status of IgVH and prognosis of CLL than CD38 expression. In addition, CD38 negativity does not necessarily indicate that IgVH mutation has occurred. These data point to the need for a more extensive study to evaluate the significance of Zap-70 and CD38 expression as indicators of IgVH mutation status and prognosis of CLL patients.
ζ链(TCR)相关蛋白激酶70kDa(Zap-70)和CD38表达可能对慢性淋巴细胞白血病(CLL)具有预后意义。先前的研究表明,在免疫球蛋白可变区基因(IgVH)未发生突变的CLL病例中,Zap-70和CD38通常呈阳性,可用于预测IgVH突变状态和预后。通常,Zap-70或CD38阳性的CLL病例预后较差。在本研究中,对47例CLL患者评估了CD38表达,对17例患者评估了Zap-70和CD38表达。在47例患者中,19例(40.4%)CD38呈阳性表达。在评估Zap-70的17例患者中,11例(64.7%)Zap-70呈阳性,而只有6例(35.3%)CD38呈阳性表达;其余病例CD38呈阴性。本研究结果表明,与CD38表达相比,Zap-70表达可能是IgVH突变状态和CLL预后的更好指标。此外,CD38阴性并不一定表明发生了IgVH突变。这些数据表明需要进行更广泛的研究,以评估Zap-70和CD38表达作为CLL患者IgVH突变状态和预后指标的意义。